Catalyst Financial Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Buy
3,386
+164
+5% +$56.1K 0.12% 95
2026
Q1
$1.13M Buy
3,222
+301
+10% +$107K 0.13% 98
2025
Q4
$956K Buy
2,921
+27
+0.9% +$8.56K 0.11% 102
2025
Q3
$817K Buy
2,894
+64
+2% +$18.6K 0.1% 109
2025
Q2
$790K Buy
2,830
+237
+9% +$67.1K 0.09% 103
2025
Q1
$808K Buy
2,593
+285
+12% +$84.2K 0.15% 86
2024
Q4
$602K Sell
2,308
-136
-6% -$40.4K 0.11% 116
2024
Q3
$787K Buy
2,444
+91
+4% +$29.8K 0.15% 86
2024
Q2
$735K Buy
2,353
+193
+9% +$56.7K 0.16% 81
2024
Q1
$570K Buy
2,160
+7
+0.3% +$2.05K 0.15% 92
2023
Q4
$620K Buy
2,153
+79
+4% +$21.5K 0.18% 79
2023
Q3
$557K Buy
2,074
+892
+75% +$223K 0.18% 81
2023
Q2
$262K Buy
1,182
+1
+0.1% +$232 0.09% 161
2023
Q1
$286K Buy
1,181
+277
+31% +$68K 0.12% 129
2022
Q4
$237K Buy
+904
New +$242K 0.12% 141

Other funds holding AMGN

Catalyst Financial Partners's AMGN Position: Q2 2026 in Review

Catalyst Financial Partners increased its Amgen (AMGN) stake by 5.1% in Q2 2026, buying an estimated $56.1K and bringing the position to 3,386 shares worth $1.23M. The position accounts for 0.12% of the portfolio, ranked #95.

Catalyst Financial Partners first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Catalyst Financial Partners held 3,386 shares of Amgen worth $1.23M as of Q2 2026.
  • Catalyst Financial Partners bought 164 Amgen shares in Q2 2026, an estimated $56.1K.
  • Amgen made up 0.12% of Catalyst Financial Partners's portfolio in Q2 2026, its #95 holding.
  • Catalyst Financial Partners first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Catalyst Financial Partners's 13F filing for Q2 2026, filed 30 Jul 2026.